Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients

We conducted a feasibility study to investigate the therapeutic effect of bevacizumab on vestibular schwannomas (VS) associated with neurofibromatosis type 2 (NF2) in a sample of Japanese patients. Ten NF2 patients were selected between 2013 and 2018: nine women and one man, with ages ranging from 1...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neurol Med Chir (Tokyo)
Main Authors: FUJII, Masazumi, ICHIKAWA, Masahiro, IWATATE, Kensho, BAKHIT, Mudathir, YAMADA, Masayuki, KUROMI, Yosuke, SATO, Taku, SAKUMA, Jun, SAITO, Kiyoshi
格式: Artigo
語言:Inglês
出版: The Japan Neurosurgical Society 2020
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7040431/
https://ncbi.nlm.nih.gov/pubmed/31902875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa.2019-0194
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍